Literature DB >> 17693090

Metallocene-based antimalarials: an exploration into the influence of the ferrocenyl moiety on in vitro antimalarial activity in chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum.

Margaret A L Blackie1, Paul Beagley, Simon L Croft, Howard Kendrick, John R Moss, Kelly Chibale.   

Abstract

To establish the role of the ferrocenyl moiety in the antiplasmodial activity of ferroquine, compounds in which this moiety is replaced by the corresponding ruthenium-based moieties were synthesized and evaluated. In both the sensitive (D10) and resistant (K1) strains of Plasmodium falciparum, ruthenoquine analogues showed comparable potency to ferroquine. This suggests that a probable role of the ferrocenyl fragment is to serve simply as a hydrophobic spacer group. In addition, ferroquine analogues with different aromatic substituents were synthesized and evaluated. Unexpectedly high activity for quinoline compounds lacking the 7-chloro substituent suggests the ferrocenyl moiety may have an additive and/or synergistic effect.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17693090     DOI: 10.1016/j.bmc.2007.07.012

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  10 in total

1.  Inhibitory activity of ferroquine, versus chloroquine, against western Kenya Plasmodium falciparum field isolates determined by a SYBR Green I in vitro assay.

Authors:  Fredrick L Eyase; Hoseah M Akala; Jacob D Johnson; Douglas S Walsh
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

2.  Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax.

Authors:  Jutta Marfurt; Ferryanto Chalfein; Pak Prayoga; Frans Wabiser; Enny Kenangalem; Kim A Piera; Barbara Machunter; Emiliana Tjitra; Nicholas M Anstey; Ric N Price
Journal:  Antimicrob Agents Chemother       Date:  2011-07-05       Impact factor: 5.191

3.  The antimalarial activity of Ru-chloroquine complexes against resistant Plasmodium falciparum is related to lipophilicity, basicity, and heme aggregation inhibition ability near water/n-octanol interfaces.

Authors:  Alberto Martínez; Chandima S K Rajapakse; Dalanda Jalloh; Cula Dautriche; Roberto A Sánchez-Delgado
Journal:  J Biol Inorg Chem       Date:  2009-04-03       Impact factor: 3.358

4.  Synthesis, characterization, and in vitro antimalarial and antitumor activity of new ruthenium(II) complexes of chloroquine.

Authors:  Chandima S K Rajapakse; Alberto Martínez; Becky Naoulou; Andrzej A Jarzecki; Liliana Suárez; Christiane Deregnaucourt; Véronique Sinou; Joseph Schrével; Elgilda Musi; Grazia Ambrosini; Gary K Schwartz; Roberto A Sánchez-Delgado
Journal:  Inorg Chem       Date:  2009-02-02       Impact factor: 5.165

Review 5.  The antimalarial ferroquine: from bench to clinic.

Authors:  C Biot; F Nosten; L Fraisse; D Ter-Minassian; J Khalife; D Dive
Journal:  Parasite       Date:  2011-08       Impact factor: 3.000

6.  6,8-Dibromo-quinoline.

Authors:  Ismail Celik; Mehmet Akkurt; Osman Cakmak; Salih Okten; Santiago García-Granda
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-10-31

Review 7.  Ferroquine and its derivatives: new generation of antimalarial agents.

Authors:  Waseem A Wani; Ehtesham Jameel; Umair Baig; Syed Mumtazuddin; Lee Ting Hun
Journal:  Eur J Med Chem       Date:  2015-07-08       Impact factor: 6.514

Review 8.  Acridine-Based Antimalarials-From the Very First Synthetic Antimalarial to Recent Developments.

Authors:  Mélanie Fonte; Natália Tassi; Paula Gomes; Cátia Teixeira
Journal:  Molecules       Date:  2021-01-24       Impact factor: 4.411

9.  Ferroquine, an ingenious antimalarial drug: thoughts on the mechanism of action.

Authors:  Faustine Dubar; Jamal Khalife; Jacques Brocard; Daniel Dive; Christophe Biot
Journal:  Molecules       Date:  2008-11-20       Impact factor: 4.411

10.  Unsymmetrical Bisquinolines with High Potency against P. falciparum Malaria.

Authors:  Katherine M Liebman; Steven J Burgess; Bornface Gunsaru; Jane X Kelly; Yuexin Li; Westin Morrill; Michael C Liebman; David H Peyton
Journal:  Molecules       Date:  2020-05-10       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.